BIAF vs NAMS (bioAffinity Technologies Inc. vs NewAmsterdam Pharma Company N.V.)
Showing Closing Date Range from Sep, 10 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Weekend Market Recess
US markets are closed for the weekend. Displaying the most recent finalized trading session. Next regular session opens Monday at 9:30 AM ET.
NAMS leads by +19.64% Alpha Spread Today
BIAF is trading at -15.34% while NAMS is at +4.30% .
Started At
Official opening auction price
Closed At
Finalized regular session close
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | BIAF | NAMS | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -15.34% | +4.30% | NAMS +19.64% |
| Net Dollar Move | $-1.44 | +$0.94 | NAMS higher move |
| Open Price | $9.96 | $22.11 | Gap: 6.07% vs 1.14% |
| Day High | $10.08 | $23.00 | Session peaks |
| Day Low | $7.82 | $21.23 | Session troughs |
| Intraday Spread | $2.26 | $1.77 | High/Low spread |
| Share Volume | 820.4K | 1.60M | NAMS more active |
| Est. Dollar Volume | $6.52M | $36.40M | NAMS higher liquidity |
Explore BIAF vs NAMS Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.